2026 Jun 12
Psychedelics Part 1: Once dismissed as relics of counterculture, psychedelics are now being studied for their potential role in mental health care. In Part 1, we speak with Dr. Rose and Dr. Rotem Petranker about the history, science, and evolving clinical landscape of psychedelics, from the early research boom of the 1960s to today's renewed interest in psilocybin- and LSD-assisted therapy. Together, they unpack how these compounds may affect the brain, why they are being studied for conditions such as depression, anxiety, PTSD, and substance use disorders, and why scientific rigour, regulation, and patient safety remain essential as the field moves from prohibition to protocol.
Sociologist; Assistant Professor in the Community & Behavioral Health Program and the Department of Sociology at the State University of New York Polytechnic Institute
Scientist-clinician; Postdoctoral Fellow at the Centre for Health Innovation and Research in Psychedelics; Doctoral Associate at the PsychoEd Clinic; Co-founder of the Canadian Centre for Psychedelic Science; Co-founder of the Psychedelic Studies Research Program at the University of Toronto
Coming soon!
